发明名称 Use of vitamin D-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives
摘要 Compounds of the formula I wherein X represents hydrogen or hydroxy; Y represents oxygen or sulphur or oxidized sulphur selected from the groups S(O) and S(O<SUB>2</SUB>); R<SUP>1 </SUP>and R<SUP>2</SUP>, which may be the same or different, represent hydrogen or a residue after removal of 1 hydrogen atom from a straight, branched or cyclic, saturated or unsaturated, C<SUB>1</SUB>-C<SUB>6</SUB>-hydrocarbon; or R<SUP>1 </SUP>and R<SUP>2</SUP>, together with the carbon atom to which they are attached (marked with an asterisk in formula I), bearing the group X, form a C<SUB>3</SUB>-C<SUB>8 </SUB>carbocyclic ring; Q represents a diradical residue after removal of 2 hydrogen atoms from a straight, branched or cyclic, saturated or unsaturated C<SUB>1</SUB>-C<SUB>8</SUB>-hydrocarbon; and R<SUP>3 </SUP>represents hydrogen or a residue after removal of 1 hydrogen atom from a straight, branched or cyclic, saturated or unsaturated C<SUB>1</SUB>-C<SUB>6</SUB>-hydrocarbon; may be used for the preparation of a medicament for the treatment and/or prophylaxis of osteoporosis and related bone disorders.
申请公布号 US7071178(B2) 申请公布日期 2006.07.04
申请号 US20010787548 申请日期 2001.05.29
申请人 LEO PHARMACEUTICAL PRODUCTS, LTD. 发明人 GRUE-SOERENSEN GUNNAR;PEDERSEN HENRIK;BINDERUP ERNST TORNDAL;TRANHOLM MIKAEL
分类号 A61K31/59;A61K31/593;A61P3/10;A61P13/12;A61P17/00;A61P17/06;A61P17/12;A61P17/16;A61P19/08;A61P19/10;A61P25/00;A61P25/28;A61P35/00;A61P35/02;A61P37/00;A61P37/06;C07C323/15;C07C323/19;C07C323/20;C07C401/00 主分类号 A61K31/59
代理机构 代理人
主权项
地址